Correlation Between Tarsus Pharmaceuticals and Morgan Stanley

Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Morgan Stanley at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Morgan Stanley into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tarsus Pharmaceuticals and Morgan Stanley Direct, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Morgan Stanley and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Morgan Stanley. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Morgan Stanley.

Diversification Opportunities for Tarsus Pharmaceuticals and Morgan Stanley

-0.13

Correlation Coefficient

Tarsus Pharmaceuticals  Morgan Stanley

Good diversification

The 3 months correlation between Tarsus and Morgan is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Morgan Stanley Direct in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Morgan Stanley Direct and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Morgan Stanley. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Morgan Stanley Direct has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Morgan Stanley go up and down completely randomly.

Pair Corralation between Tarsus Pharmaceuticals and Morgan Stanley

Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to under-perform the Morgan Stanley. In addition to that, Tarsus Pharmaceuticals is 3.23 times more volatile than Morgan Stanley Direct. It trades about -0.07 of its total potential returns per unit of risk. Morgan Stanley Direct is currently generating about -0.01 per unit of volatility. If you would invest  2,059  in Morgan Stanley Direct on December 3, 2024 and sell it today you would lose (16.00) from holding Morgan Stanley Direct or give up 0.78% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Tarsus Pharmaceuticals  vs.  Morgan Stanley Direct

Tarsus Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Tarsus Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Morgan Stanley Direct

Risk-Adjusted Performance

Very Weak

Over the last 90 days Morgan Stanley Direct has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent fundamental indicators, Morgan Stanley is not utilizing all of its potentials. The newest stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Tarsus Pharmaceuticals and Morgan Stanley

The main advantage of trading using opposite Tarsus Pharmaceuticals and Morgan Stanley positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Morgan Stanley can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Morgan Stanley will offset losses from the drop in Morgan Stanley's long position.

The idea behind Tarsus Pharmaceuticals and Morgan Stanley Direct pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.